CONCLUSIONS: Our findings demonstrate that by combining competitive occupancy of NRP1 with potent anti-angiogenic signaling, SEMA-PSI-IG-HBD represents a promising therapeutic candidate for the regulation of pathological vascularization in cancer. This evidence concerns the gene NRP1 and cancer.